关注
Miyamoto Yuji
Miyamoto Yuji
在 kumamoto-u.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer
Y Miyamoto, Y Baba, Y Sakamoto, M Ohuchi, R Tokunaga, J Kurashige, ...
Annals of surgical oncology 22, 2663-2668, 2015
3202015
Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection
R Tokunaga, Y Sakamoto, S Nakagawa, Y Miyamoto, N Yoshida, E Oki, ...
Diseases of the Colon & Rectum 58 (11), 1048-1057, 2015
2342015
Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer
K Okadome, Y Baba, T Yagi, Y Kiyozumi, T Ishimoto, M Iwatsuki, ...
Annals of Surgery 271 (4), 693-700, 2020
2102020
Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma
Y Baba, N Yoshida, H Shigaki, M Iwatsuki, Y Miyamoto, Y Sakamoto, ...
Annals of surgery 264 (2), 305-311, 2016
1692016
CXCL12/CXCR4 activation by cancer‐associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer
D Izumi, T Ishimoto, K Miyake, H Sugihara, K Eto, H Sawayama, T Yasuda, ...
International journal of cancer 138 (5), 1207-1219, 2016
1632016
PD-L1 expression, tumor-infiltrating lymphocytes, and clinical outcome in patients with surgically resected esophageal cancer
T Yagi, Y Baba, T Ishimoto, M Iwatsuki, Y Miyamoto, N Yoshida, ...
Annals of surgery 269 (3), 471-478, 2019
1452019
CD 169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma
K Ohnishi, Y Komohara, Y Saito, Y Miyamoto, M Watanabe, H Baba, ...
Cancer science 104 (9), 1237-1244, 2013
1382013
Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer
Y Miyamoto, Y Baba, Y Sakamoto, M Ohuchi, R Tokunaga, J Kurashige, ...
PloS one 10 (6), e0129742, 2015
1372015
Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer
N Yoshida, Y Baba, H Shigaki, K Harada, M Iwatsuki, J Kurashige, ...
World journal of surgery 40, 1910-1917, 2016
1362016
CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection
R Tokunaga, Y Sakamoto, S Nakagawa, M Ohuchi, D Izumi, K Kosumi, ...
International journal of colorectal disease 32, 99-106, 2017
1262017
Risk factors for pulmonary complications after esophagectomy for esophageal cancer
N Yoshida, M Watanabe, Y Baba, S Iwagami, T Ishimoto, M Iwatsuki, ...
Surgery today 44, 526-532, 2014
1222014
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
Y Baba, D Nomoto, K Okadome, T Ishimoto, M Iwatsuki, Y Miyamoto, ...
Cancer science 111 (9), 3132-3141, 2020
1182020
Mieap, a p53-inducible protein, controls mitochondrial quality by repairing or eliminating unhealthy mitochondria
N Kitamura, Y Nakamura, Y Miyamoto, T Miyamoto, K Kabu, M Yoshida, ...
PloS one 6 (1), e16060, 2011
1182011
The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage
Y Masuda, M Futamura, H Kamino, Y Nakamura, N Kitamura, S Ohnishi, ...
Journal of human genetics 51 (8), 652-664, 2006
1152006
Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21. 3, in p53-regulated tumor angiogenesis suppression
M Futamura, H Kamino, Y Miyamoto, N Kitamura, Y Nakamura, S Ohnishi, ...
Cancer research 67 (4), 1451-1460, 2007
1092007
The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab
K Eto, M Iwatsuki, M Watanabe, S Ida, T Ishimoto, S Iwagami, Y Baba, ...
Annals of surgical oncology 21, 343-350, 2014
1062014
The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity
H Sato, Y Taketomi, A Ushida, Y Isogai, T Kojima, T Hirabayashi, Y Miki, ...
Cell metabolism 20 (1), 119-132, 2014
1052014
Molecular pathways: cachexia signaling—a targeted approach to cancer treatment
Y Miyamoto, DL Hanna, W Zhang, H Baba, HJ Lenz
Clinical Cancer Research 22 (16), 3999-4004, 2016
1042016
CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
S Saito, H Okabe, M Watanabe, T Ishimoto, M Iwatsuki, Y Baba, Y Tanaka, ...
Oncology reports 29 (4), 1570-1578, 2013
1002013
The sensitivity of gastric cancer to trastuzumab is regulated by the mi R‐223/FBXW 7 pathway
K Eto, M Iwatsuki, M Watanabe, T Ishimoto, S Ida, Y Imamura, S Iwagami, ...
International journal of cancer 136 (7), 1537-1545, 2015
952015
系统目前无法执行此操作,请稍后再试。
文章 1–20